If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Acadia Pharmaceuticals (ACAD) just stacked two key clinical milestones: a fresh USPTO Notice of Allowance extending potential ...

Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings ...

Investment firm RBC said the patent litigation between Acadia Pharmaceuticals (ACAD) and generic drugmaker Zydus over Nuplazid appears to have been resolved. Shares of Acadia Pharmaceuticals turned ...

-- First and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000 to 9,000 patients in the U.S. 1 SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals ( ACAD) sank almost 7% on Friday, closing at $20.68 after a drop of $1.50. This came after a 13% drop ...

Catherine E. Owen Adams, CEO, stated that "Our second quarter performance reinforces the momentum we're building across all facets of our business from commercial strength to our clinical pipeline and ...

General Motors downsized the people-moving Acadia for its second generation, but for three-row-conscious consumers, the company reversed course for its third installment. The third-generation GMC ...

Editor’s Note: CNN.com’s weekly Summer in the Park series turns to rangers at the United States’ most popular national parks to get insider recommendations for your visits, whether you have just one ...

Back in 2006, large 3-row crossover utility vehicles based on unibody, car-derived platforms rather than body-on-frame SUVs weren’t particularly common yet. The Honda Pilot and Toyota Highlander were ...